Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (1317)	11/1/1999 1:56:00 PM
From: ClearSky	Read Replies (1) \| Respond to of 5582

Dan, I read about Zicam in a fitness-type magazine and so I had some prior awareness of it. Saw the stock moving this a.m., checked out the Zicam website and called the company (partly for IR purposes, partly because of the appeal of a product to shorten the life of a cold.) So...I heard about GUMM via SI and checked out the stock. While the Zicam PR doesn't tout GUMM, the Zicam website does explain GUMM's interest, under Investor Relations. Thanks for the info. Jeanne

To: DanZ who wrote (1317)	11/1/1999 4:45:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

You might have noticed that the article in USA Today didn't even mention GumTech. It is my understanding that GumTech specifically requested this because they didn't want to hype their stock. They want to sell Zicam, not their stock. Probably means we have another day or two of discovery for investors before this short run rests....Just about enough time to start getting nervous about the 2d study and any announcement regarding nicotine.... Sometimes, being a bear is just no fun. You can lead a bear to water...